Colorectal Cancer News and reporting on colorectal cancer. Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape Premium The data, while limited, indicate that the firm's blood-only assay may be able to match the performance of existing commercial tissue-informed competitors. Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research Indivumed and the Oslo University Hospital's Institute for Cancer Genetics and Informatics will develop algorithms to automate colorectal cancer prognoses. Aiming to Cut Unnecessary Surgeries, City of Hope Team to Commercialize CRC Metastasis Dx Signature Premium The team will use the reverse-transcriptase quantitative PCR test, which uses a milliliter of a patient's blood, to curb unneeded radical colon cancer surgeries. Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer The assay is intended to detect Guardant Health Receives New York State Approval for Guardant Reveal MRD Test The assay is Guardant Health’s first commercially available product for clinical management of early-stage tumors and is initially focused on colorectal cancer. Nov 29, 2016 Genetic Technologies Licenses Colorectal Cancer Risk Assessment Technology Oct 26, 2016 USPSTF Guidelines May Have Used Old Data on Epigenomics Colorectal Cancer Screening Test Oct 26, 2016 Exact Sciences Q3 Revenues Soar 123 Percent Oct 19, 2016 Clinical Genomics Publishes Data Showing Colorectal Cancer Test Outperforms Current Standard Premium Oct 17, 2016 Exact Sciences Gets Coverage from DoD for Cologuard Screening Test Oct 13, 2016 Acuamark Diagnostics Raising Funds to Finance Early Detection Dx Development Premium Oct 3, 2016 KRAS-Driven Tumor Growth Inhibited by MicroRNA Sep 29, 2016 New Legislation Would Require CMS Coverage for Blood-Based Colorectal Cancer Screens Aug 31, 2016 Owlstone Medical Making Push to Commercialize 'Breathalyzer' Diagnostic Test for Lung, Colon Cancer Premium Aug 23, 2016 NY State Rescinds Conditional Approval of Four Rosetta Genomics PCR Assays Aug 15, 2016 CMS Affirms Coverage of Exact Sciences' Cologuard Test for Medicare Advantage Plans Aug 10, 2016 Epigenomics Q2 Revenues Up 159 Percent Aug 2, 2016 Sequenom Leads GWDN Index Rally in July on News of Acquisition by LabCorp Jul 29, 2016 Trovagene's Dual-Sample Liquid Biopsy Performs Well in First Peer-Reviewed Study Premium Jul 29, 2016 Hereditary Colorectal Cancer Syndrome Caused by Recessive Mutations in Mismatch Repair Gene Jul 28, 2016 Exact Sciences Plans Public Offering of 8.5M Shares Jul 28, 2016 CellMax Life Aims to Advance CTC-Based Early Cancer Detection; Clinical Studies Ongoing Premium Jul 28, 2016 Merck KGaA, AmoyDx Partner on Colorectal Cancer Test for Chinese Market Jul 26, 2016 Exact Sciences Revenues More Than Double on Cologuard Sales Jul 26, 2016 CellMax Life Launches With $14M in Funding, Early Colorectal Cancer Detection Test Load More Breaking News Genomtec Gets CE-IVD Mark for Saliva-Based Molecular SARS-CoV-2 Test Oncocyte Posts $1.1M in Q1 Revenues, Beating Wall Street Expectations Namocell, SingLab Technologies Ink Distribution Agreement for Singapore Mitochondrial DNA Analysis Uncovers Influence of Genetic Variation on Hundreds of Phenotypes Bipolar Disorder GWAS Meta-Analysis Points to Potential Treatment Targets Ginkgo Bioworks Acquires Dutch DNA Biotech The Scan Gap in COVAX Doses BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports. Sanofi, GSK Report Promising Results The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results. Influence of Luck The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases. PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.